Prowill Pharmaceuticals Private Limited, a active private limited company, was established on 30 March 2012 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999MH2012PTC229057. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.16 Cr and a paid-up capital of ₹4.75 Cr.
It upholds a compliant status. Employing 9 professional, Its leadership includes Santosh Shrikrishna Joshi (Director), Varsha Santosh Joshi (Director). Past directors included Suhas Ramesh Ghuge, Dagadu Ganpat Bansode, Santosh Shrikrishna Joshi. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at J. P. House, Plot No. D--28/16, M.I.D.C., T.T.C. Industrial Area, Turbhe, Navi Mum, Bai, Navi Mumbai, Maharashtra, 400705.
U74999MH2012PTC229057
229057
30 March 2012
₹5.16 Cr
₹4.75 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Prowill Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santosh Shrikrishna Joshi | Director | 17 Jul 2020 | Current |
| Varsha Santosh Joshi | Director | 18 Jul 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Jul 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 04 Nov 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Prowill Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.93% increase. The company also saw a substantial improvement in profitability, with a 115.02% increase in profit. The company's net worth Soared by an impressive increase of 25.5%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Prowill Pharmaceuticals had a promoter holding of 82.69% and a public holding of 17.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Prowill Pharmaceuticals has a workforce of 9 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Prowill Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prowill Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Prowill Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Prowill Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on Varsha Santosh Joshi was appointed as a Director was appointed as a Director on 18 Jul 2022 & has been associated with this company since 3 years 4 months . was documented.
The activity Santosh Shrikrishna Joshi was appointed as a Director was appointed as a Director on 17 Jul 2020 & has been associated with this company since 5 years 4 months . was completed.
Prowill Pharmaceuticals Private Limited was registered on 30 Mar 2012 with Roc Mumbai & aged 13 years 8 months as per MCA records. was recorded as a recent event.
The CIN of Prowill Pharmaceuticals Private Limited is U74999MH2012PTC229057.
Prowill Pharmaceuticals Private Limited is headquartered at J. P. House, Plot No. D--28/16, M.I.D.C., T.T.C. Industrial Area, Turbhe, Navi Mum, Bai, Navi Mumbai, Maharashtra, 400705.
Prowill Pharmaceuticals Private Limited was incorporated on 30 March 2012.
The current directors of Prowill Pharmaceuticals Private Limited are
The primary industry of Prowill Pharmaceuticals Private Limited is Manufacturing.
Prowill Pharmaceuticals Private Limited is unlisted.
The authorized capital of Prowill Pharmaceuticals Private Limited is ₹5.16 Cr, and the paid-up capital is ₹4.75 Cr.
The compliance status of Prowill Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX